Europe Sees Substantial Growth Backed by Strong Healthcare Systems and Reimbursement Policies The Europe GLP-1 receptor agonist market is projected to witness substantial growth during the forecast period due to strong healthcare systems, widespread clinical acceptance of GLP-1 therapies, and rising focus on integrating diabetes devices and obesity management
Route: Subcutaneous injection (abdomen, thighs, or upper arms)
And shout out to the Obesity Medicine Association celebrating 75 years of educating and advocacy on obesity
Mounjaro (tirzepatide) While Mounjaro (tirzepatide) belongs to the GLP-1 medication family, it differs from other GLP-1 agonists like Ozempic
Could Your Gut Be the Cause
In terms of service, our company will continue to adhere to the business philosophy of customer first, constantly improve customer service level and improve customer loyalty